Yuuwa Capital makes second life sciences investment into OzSonotek

Yuuwa Capital has completed its second Life Science investment into OzSonotek Pty Ltd,  a Perth-based ophthalmic medical device company.

OzSonotek’s first product is a next generation needle for phacoemulsification cataract surgery. The new needle provides significant surgical performance benefits over existing technologies in a market that completes more than 10 million procedures a year.

Yuuwa Capital Investment Directors James Williams and Liddy McCall have direct experience taking ophthalmic devices to market, and will complement the board and management’s expertise to allow this first product to progress rapidly to market.

The Press Announcement is linked here: Yuuwa OzSonotek Agreement Press Release

Leave a Reply